| JBALX | RLBFX | JBALX / RLBFX | |
| Total Expense Ratio | 0.66 | 0.29 | 228% |
| Annual Report Gross Expense Ratio | 0.66 | 0.29 | 228% |
| Fund Existence | 17 years | 24 years | - |
| Gain YTD | -0.393 | 2.503 | -16% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 28.3B | 270B | 10% |
| Annual Yield % from dividends | 1.74 | 2.13 | 82% |
| Returns for 1 year | 5.33 | 11.69 | 46% |
| Returns for 3 years | 29.12 | 38.02 | 77% |
| Returns for 5 years | 26.14 | 37.38 | 70% |
| Returns for 10 years | 110.64 | 91.94 | 120% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NVIR | 36.36 | 0.49 | +1.37% |
| Horizon Kinetics Energy Remediation ETF | |||
| MDYG | 97.07 | -0.04 | -0.04% |
| State Street® SPDR® S&P 400™ Md Cp GrETF | |||
| BIB | 84.81 | -0.16 | -0.19% |
| ProShares Ultra Nasdaq Biotechnology | |||
| AIVL | 119.42 | -0.30 | -0.25% |
| WisdomTree US Al Enhanced Val ETF | |||
| NVDG | 15.46 | -0.94 | -5.73% |
| Leverage Shares 2X Long Nvda Daily ETF | |||